| ■ 영문 제목 : Global Iritis Ophthalmic Drugs Market Growth 2021-2026 | |
 | ■ 상품코드 : LPI-2201K00074 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 95 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의료, 제약 |
| Single User (1명 열람용) | USD3,660 ⇒환산￦4,941,000 | 견적의뢰/주문/질문 |
| Multi User (5명 열람용) | USD5,490 ⇒환산￦7,411,500 | 견적의뢰/주문/질문 |
| Corporate User (동일기업내 공유가능) | USD7,320 ⇒환산￦9,882,000 | 견적의뢰/구입/질문 |
|
※가격옵션 설명 - 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다. - 지불방법은 계좌이체/무통장입금 또는 카드결제입니다. |
| 본 조사보고서는 포도막염 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (확장제, 항감염제, 기타)와 용도별 시장규모 (병원, 클리닉, 가정용, 기타) 데이터도 수록되어 있습니다. - 조사 범위 - 경영자용 요약 - 기업별 포도막염 치료제 시장 점유율 - 지역별 포도막염 치료제 시장규모 - 주요지역의 종류별 시장규모 (확장제, 항감염제, 기타) - 주요지역의 용도별 시장규모 (병원, 클리닉, 가정용, 기타) - 미주의 포도막염 치료제 시장규모 (미국, 캐나다, 멕시코, 브라질 등) - 아시아의 포도막염 치료제 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등) - 유럽의 포도막염 치료제 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등) - 중동/아프리카의 포도막염 치료제 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등) - 시장의 성장요인, 과제, 동향 - 마케팅, 유통업자, 고객리스트 - 세계의 포도막염 치료제 시장예측 (2021년-2026년) - 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) Novartis, Allergan, Bausch Health, Santen Pharmaceutical, Lupin Pharmaceuticals, Apotex, Akorn, Senju Pharmaceutical - 조사의 결과/결론 |
According to this latest study, the 2021 growth of Iritis Ophthalmic Drugs will have significant change from previous year. By the most conservative estimates of global Iritis Ophthalmic Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Iritis Ophthalmic Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Iritis Ophthalmic Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Dilation Drugs
Anti-infective Drugs
Other
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Hospital
Clinic
Household
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Novartis
Allergan
Bausch Health
Santen Pharmaceutical
Lupin Pharmaceuticals
Apotex
Akorn
Senju Pharmaceutical
1 Scope of the Report 2 Executive Summary 3 Global Iritis Ophthalmic Drugs by Company 4 Iritis Ophthalmic Drugs by Region 5 Americas 6 APAC 7 Europe 8 Middle East & Africa 9 Market Drivers, Challenges and Trends 10 Marketing, Distributors and Customer 11 Global Iritis Ophthalmic Drugs Market Forecast 12 Key Players Analysis 13 Research Findings and Conclusion List of TablesTable 1. Iritis Ophthalmic Drugs Consumption CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Dilation Drugs Table 3. Major Players of Anti-infective Drugs Table 4. Major Players of Other Table 5. Global Iritis Ophthalmic Drugs Sales by Type (2016-2021) & (K Units) Table 6. Global Iritis Ophthalmic Drugs Sales Market Share by Type (2016-2021) Table 7. Global Iritis Ophthalmic Drugs Revenue by Type (2016-2021) & ($ million) Table 8. Global Iritis Ophthalmic Drugs Revenue Market Share by Type (2016-2021) Table 9. Global Iritis Ophthalmic Drugs Sale Price by Type (2016-2021) Table 10. Global Iritis Ophthalmic Drugs Sales by Application (2016-2021) & (K Units) Table 11. Global Iritis Ophthalmic Drugs Sales Market Share by Application (2016-2021) Table 12. Global Iritis Ophthalmic Drugs Value by Application (2016-2021) Table 13. Global Iritis Ophthalmic Drugs Revenue Market Share by Application (2016-2021) Table 14. Global Iritis Ophthalmic Drugs Sale Price by Application (2016-2021) Table 15. Global Iritis Ophthalmic Drugs Sales by Company (2019-2021) & (K Units) Table 16. Global Iritis Ophthalmic Drugs Sales Market Share by Company (2019-2021) Table 17. Global Iritis Ophthalmic Drugs Revenue by Company (2019-2021) ($ Millions) Table 18. Global Iritis Ophthalmic Drugs Revenue Market Share by Company (2019-2021) Table 19. Global Iritis Ophthalmic Drugs Sale Price by Company (2019-2021) Table 20. Key Manufacturers Iritis Ophthalmic Drugs Producing Area Distribution and Sales Area Table 21. Players Iritis Ophthalmic Drugs Products Offered Table 22. Iritis Ophthalmic Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) Table 23. New Products and Potential Entrants Table 24. Mergers & Acquisitions, Expansion Table 25. Global Iritis Ophthalmic Drugs Sales by Region (2016-2021) (K Units) Table 26. Global Iritis Ophthalmic Drugs Sales Market Share by Region (2016-2021) Table 27. Global Iritis Ophthalmic Drugs Revenue by Region (2016-2021) & ($ Millions) Table 28. Global Iritis Ophthalmic Drugs Revenue Market Share by Region (2016-2021) Table 29. Americas Iritis Ophthalmic Drugs Sales by Country (2016-2021) & (K Units) Table 30. Americas Iritis Ophthalmic Drugs Sales Market Share by Country (2016-2021) Table 31. Americas Iritis Ophthalmic Drugs Revenue by Country (2016-2021) & ($ Millions) Table 32. Americas Iritis Ophthalmic Drugs Revenue Market Share by Country (2016-2021) Table 33. Americas Iritis Ophthalmic Drugs Sales by Type (2016-2021) & (K Units) Table 34. Americas Iritis Ophthalmic Drugs Sales Market Share by Type (2016-2021) Table 35. Americas Iritis Ophthalmic Drugs Sales by Application (2016-2021) & (K Units) Table 36. Americas Iritis Ophthalmic Drugs Sales Market Share by Application (2016-2021) Table 37. APAC Iritis Ophthalmic Drugs Sales by Region (2016-2021) & (K Units) Table 38. APAC Iritis Ophthalmic Drugs Sales Market Share by Region (2016-2021) Table 39. APAC Iritis Ophthalmic Drugs Revenue by Region (2016-2021) & ($ Millions) Table 40. APAC Iritis Ophthalmic Drugs Revenue Market Share by Region (2016-2021) Table 41. APAC Iritis Ophthalmic Drugs Sales by Type (2016-2021) & (K Units) Table 42. APAC Iritis Ophthalmic Drugs Sales Market Share by Type (2016-2021) Table 43. APAC Iritis Ophthalmic Drugs Sales by Application (2016-2021) & (K Units) Table 44. APAC Iritis Ophthalmic Drugs Sales Market Share by Application (2016-2021) Table 45. Europe Iritis Ophthalmic Drugs Sales by Country (2016-2021) & (K Units) Table 46. Europe Iritis Ophthalmic Drugs Sales Market Share by Country (2016-2021) Table 47. Europe Iritis Ophthalmic Drugs Revenue by Country (2016-2021) & ($ Millions) Table 48. Europe Iritis Ophthalmic Drugs Revenue Market Share by Country (2016-2021) Table 49. Europe Iritis Ophthalmic Drugs Sales by Type (2016-2021) & (K Units) Table 50. Europe Iritis Ophthalmic Drugs Sales Market Share by Type (2016-2021) Table 51. Europe Iritis Ophthalmic Drugs Sales by Application (2016-2021) & (K Units) Table 52. Europe Iritis Ophthalmic Drugs Sales Market Share by Application (2016-2021) Table 53. Middle East & Africa Iritis Ophthalmic Drugs Sales by Country (2016-2021) & (K Units) Table 54. Middle East & Africa Iritis Ophthalmic Drugs Sales Market Share by Country (2016-2021) Table 55. Middle East & Africa Iritis Ophthalmic Drugs Revenue by Country (2016-2021) & ($ Millions) Table 56. Middle East & Africa Iritis Ophthalmic Drugs Revenue Market Share by Country (2016-2021) Table 57. Middle East & Africa Iritis Ophthalmic Drugs Sales by Type (2016-2021) & (K Units) Table 58. Middle East & Africa Iritis Ophthalmic Drugs Sales Market Share by Type (2016-2021) Table 59. Middle East & Africa Iritis Ophthalmic Drugs Sales by Application (2016-2021) & (K Units) Table 60. Middle East & Africa Iritis Ophthalmic Drugs Sales Market Share by Application (2016-2021) Table 61. Key and Potential Regions of Iritis Ophthalmic Drugs Table 62. Key Application and Potential Industries of Iritis Ophthalmic Drugs Table 63. Key Challenges of Iritis Ophthalmic Drugs Table 64. Key Trends of Iritis Ophthalmic Drugs Table 65. Iritis Ophthalmic Drugs Distributors List Table 66. Iritis Ophthalmic Drugs Customer List Table 67. Global Iritis Ophthalmic Drugs Sales Forecast by Region (2021-2026) & (K Units) Table 68. Global Iritis Ophthalmic Drugs Consumption Market Forecast by Region Table 69. Global Iritis Ophthalmic Drugs Revenue Forecast by Region (2021-2026) & ($ millions) Table 70. Global Iritis Ophthalmic Drugs Revenue Market Share Forecast by Region (2021-2026) Table 71. Americas Iritis Ophthalmic Drugs Sales Forecast by Country (2021-2026) & (K Units) Table 72. Americas Iritis Ophthalmic Drugs Revenue Forecast by Country (2021-2026) & ($ millions) Table 73. APAC Iritis Ophthalmic Drugs Sales Forecast by Region (2021-2026) & (K Units) Table 74. APAC Iritis Ophthalmic Drugs Revenue Forecast by Region (2021-2026) & ($ millions) Table 75. Europe Iritis Ophthalmic Drugs Sales Forecast by Country (2021-2026) & (K Units) Table 76. Europe Iritis Ophthalmic Drugs Revenue Forecast by Country (2021-2026) & ($ millions) Table 77. Middle East & Africa Iritis Ophthalmic Drugs Sales Forecast by Country (2021-2026) & (K Units) Table 78. Middle East & Africa Iritis Ophthalmic Drugs Revenue Forecast by Country (2021-2026) & ($ millions) Table 79. Global Iritis Ophthalmic Drugs Sales Forecast by Type (2021-2026) & (K Units) Table 80. Global Iritis Ophthalmic Drugs Sales Market Share Forecast by Type (2021-2026) Table 81. Global Iritis Ophthalmic Drugs Revenue Forecast by Type (2021-2026) & ($ Millions) Table 82. Global Iritis Ophthalmic Drugs Revenue Market Share Forecast by Type (2021-2026) Table 83. Global Iritis Ophthalmic Drugs Sales Forecast by Application (2021-2026) & (K Units) Table 84. Global Iritis Ophthalmic Drugs Sales Market Share Forecast by Application (2021-2026) Table 85. Global Iritis Ophthalmic Drugs Revenue Forecast by Application (2021-2026) & ($ Millions) Table 86. Global Iritis Ophthalmic Drugs Revenue Market Share Forecast by Application (2021-2026) Table 87. Novartis Basic Information, Iritis Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors Table 88. Novartis Iritis Ophthalmic Drugs Product Offered Table 89. Novartis Iritis Ophthalmic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 90. Novartis Main Business Table 91. Novartis Latest Developments Table 92. Allergan Basic Information, Iritis Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors Table 93. Allergan Iritis Ophthalmic Drugs Product Offered Table 94. Allergan Iritis Ophthalmic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 95. Allergan Main Business Table 96. Allergan Latest Developments Table 97. Bausch Health Basic Information, Iritis Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors Table 98. Bausch Health Iritis Ophthalmic Drugs Product Offered Table 99. Bausch Health Iritis Ophthalmic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 100. Bausch Health Main Business Table 101. Bausch Health Latest Developments Table 102. Santen Pharmaceutical Basic Information, Iritis Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors Table 103. Santen Pharmaceutical Iritis Ophthalmic Drugs Product Offered Table 104. Santen Pharmaceutical Iritis Ophthalmic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 105. Santen Pharmaceutical Main Business Table 106. Santen Pharmaceutical Latest Developments Table 107. Lupin Pharmaceuticals Basic Information, Iritis Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors Table 108. Lupin Pharmaceuticals Iritis Ophthalmic Drugs Product Offered Table 109. Lupin Pharmaceuticals Iritis Ophthalmic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 110. Lupin Pharmaceuticals Main Business Table 111. Lupin Pharmaceuticals Latest Developments Table 112. Apotex Basic Information, Iritis Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors Table 113. Apotex Iritis Ophthalmic Drugs Product Offered Table 114. Apotex Iritis Ophthalmic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 115. Apotex Main Business Table 116. Apotex Latest Developments Table 117. Akorn Basic Information, Iritis Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors Table 118. Akorn Iritis Ophthalmic Drugs Product Offered Table 119. Akorn Iritis Ophthalmic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 120. Akorn Main Business Table 121. Akorn Latest Developments Table 122. Senju Pharmaceutical Basic Information, Iritis Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors Table 123. Senju Pharmaceutical Iritis Ophthalmic Drugs Product Offered Table 124. Senju Pharmaceutical Iritis Ophthalmic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 125. Senju Pharmaceutical Main Business Table 126. Senju Pharmaceutical Latest Developments List of Figures Figure 1. Picture of Iritis Ophthalmic Drugs Figure 2. Iritis Ophthalmic Drugs Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Iritis Ophthalmic Drugs Sales Growth Rate 2016-2026 (K Units) Figure 7. Global Iritis Ophthalmic Drugs Revenue Growth Rate 2016-2026 ($ Millions) Figure 8. Iritis Ophthalmic Drugs Sales by Region (2021 & 2026) & ($ millions) Figure 9. Product Picture of Dilation Drugs Figure 10. Product Picture of Anti-infective Drugs Figure 11. Product Picture of Other Figure 12. Global Iritis Ophthalmic Drugs Sales Market Share by Type in 2020 Figure 13. Global Iritis Ophthalmic Drugs Revenue Market Share by Type (2016-2021) Figure 14. Iritis Ophthalmic Drugs Consumed in Hospital Figure 15. Global Iritis Ophthalmic Drugs Market: Hospital (2016-2021) & (K Units) Figure 16. Iritis Ophthalmic Drugs Consumed in Clinic Figure 17. Global Iritis Ophthalmic Drugs Market: Clinic (2016-2021) & (K Units) Figure 18. Iritis Ophthalmic Drugs Consumed in Household Figure 19. Global Iritis Ophthalmic Drugs Market: Household (2016-2021) & (K Units) Figure 20. Iritis Ophthalmic Drugs Consumed in Others Figure 21. Global Iritis Ophthalmic Drugs Market: Others (2016-2021) & (K Units) Figure 22. Global Iritis Ophthalmic Drugs Sales Market Share by Application (2016-2021) Figure 23. Global Iritis Ophthalmic Drugs Revenue Market Share by Application in 2020 Figure 24. Iritis Ophthalmic Drugs Revenue Market by Company in 2020 ($ Million) Figure 25. Global Iritis Ophthalmic Drugs Revenue Market Share by Company in 2020 Figure 26. Global Iritis Ophthalmic Drugs Sales Market Share by Regions (2016-2021) Figure 27. Global Iritis Ophthalmic Drugs Revenue Market Share by Region in 2020 Figure 28. Americas Iritis Ophthalmic Drugs Sales 2016-2021 (K Units) Figure 29. Americas Iritis Ophthalmic Drugs Revenue 2016-2021 ($ Millions) Figure 30. APAC Iritis Ophthalmic Drugs Sales 2016-2021 (K Units) Figure 31. APAC Iritis Ophthalmic Drugs Revenue 2016-2021 ($ Millions) Figure 32. Europe Iritis Ophthalmic Drugs Sales 2016-2021 (K Units) Figure 33. Europe Iritis Ophthalmic Drugs Revenue 2016-2021 ($ Millions) Figure 34. Middle East & Africa Iritis Ophthalmic Drugs Sales 2016-2021 (K Units) Figure 35. Middle East & Africa Iritis Ophthalmic Drugs Revenue 2016-2021 ($ Millions) Figure 36. Americas Iritis Ophthalmic Drugs Sales Market Share by Country in 2020 Figure 37. Americas Iritis Ophthalmic Drugs Revenue Market Share by Country in 2020 Figure 38. Americas Iritis Ophthalmic Drugs Sales Market Share by Type in 2020 Figure 39. Americas Iritis Ophthalmic Drugs Sales Market Share by Application in 2020 Figure 40. United States Iritis Ophthalmic Drugs Revenue Growth 2016-2021 ($ Millions) Figure 41. Canada Iritis Ophthalmic Drugs Revenue Growth 2016-2021 ($ Millions) Figure 42. Mexico Iritis Ophthalmic Drugs Revenue Growth 2016-2021 ($ Millions) Figure 43. Brazil Iritis Ophthalmic Drugs Revenue Growth 2016-2021 ($ Millions) Figure 44. APAC Iritis Ophthalmic Drugs Sales Market Share by Region in 2020 Figure 45. APAC Iritis Ophthalmic Drugs Revenue Market Share by Regions in 2020 Figure 46. APAC Iritis Ophthalmic Drugs Sales Market Share by Type in 2020 Figure 47. APAC Iritis Ophthalmic Drugs Sales Market Share by Application in 2020 Figure 48. China Iritis Ophthalmic Drugs Revenue Growth 2016-2021 ($ Millions) Figure 49. Japan Iritis Ophthalmic Drugs Revenue Growth 2016-2021 ($ Millions) Figure 50. Korea Iritis Ophthalmic Drugs Revenue Growth 2016-2021 ($ Millions) Figure 51. Southeast Asia Iritis Ophthalmic Drugs Revenue Growth 2016-2021 ($ Millions) Figure 52. India Iritis Ophthalmic Drugs Revenue Growth 2016-2021 ($ Millions) Figure 53. Australia Iritis Ophthalmic Drugs Revenue Growth 2016-2021 ($ Millions) Figure 54. Europe Iritis Ophthalmic Drugs Sales Market Share by Country in 2020 Figure 55. Europe Iritis Ophthalmic Drugs Revenue Market Share by Country in 2020 Figure 56. Europe Iritis Ophthalmic Drugs Sales Market Share by Type in 2020 Figure 57. Europe Iritis Ophthalmic Drugs Sales Market Share by Application in 2020 Figure 58. Germany Iritis Ophthalmic Drugs Revenue Growth 2016-2021 ($ Millions) Figure 59. France Iritis Ophthalmic Drugs Revenue Growth 2016-2021 ($ Millions) Figure 60. UK Iritis Ophthalmic Drugs Revenue Growth 2016-2021 ($ Millions) Figure 61. Italy Iritis Ophthalmic Drugs Revenue Growth 2016-2021 ($ Millions) Figure 62. Russia Iritis Ophthalmic Drugs Revenue Growth 2016-2021 ($ Millions) Figure 63. Middle East & Africa Iritis Ophthalmic Drugs Sales Market Share by Country in 2020 Figure 64. Middle East & Africa Iritis Ophthalmic Drugs Revenue Market Share by Country in 2020 Figure 65. Middle East & Africa Iritis Ophthalmic Drugs Sales Market Share by Type in 2020 Figure 66. Middle East & Africa Iritis Ophthalmic Drugs Sales Market Share by Application in 2020 Figure 67. Egypt Iritis Ophthalmic Drugs Revenue Growth 2016-2021 ($ Millions) Figure 68. South Africa Iritis Ophthalmic Drugs Revenue Growth 2016-2021 ($ Millions) Figure 69. Israel Iritis Ophthalmic Drugs Revenue Growth 2016-2021 ($ Millions) Figure 70. Turkey Iritis Ophthalmic Drugs Revenue Growth 2016-2021 ($ Millions) Figure 71. GCC Country Iritis Ophthalmic Drugs Revenue Growth 2016-2021 ($ Millions) Figure 72. Channels of Distribution Figure 73. Distributors Profiles |
| ※본 조사보고서 [세계의 포도막염 치료제 시장예측 2021년-2026년] (코드 : LPI-2201K00074) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 포도막염 치료제 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요. |